Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®
NCT01228565
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Carcinoma
Interventions
OTHER:
Radiotherapy + Erbitux® + placebo
OTHER:
Radiotherapy+Erbitux+OTD70DERM
Sponsor
Groupe Oncologie Radiotherapie Tete et Cou